Medicure, Inc. (NASDAQ:MCUJF)

BRIEF

published on 04/24/2026 at 00:20, 8 days ago

Medicure's 2025 Financial Results Indicate Revenue Growth Amid Losses

Financial Results Net Revenue AGGRASTAT R&D Expenses Pharmacy Segment
PRESS RELEASE

published on 04/24/2026 at 00:15, 8 days ago

Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
Medicure Inc. reports financial results for the year ended December 31, 2025, with total net revenue of $28.9 million and plans a conference call on April 27, 2026 at 8:30 am Eastern Time

Financial Results Conference Call Pharmaceuticals Medicure Inc. Net Revenue
BRIEF

published on 04/18/2026 at 01:40, 13 days 23 hours ago

Medicure Announces Leadership Change

Pharmaceuticals Strategic Priorities Medicure Inc. Leadership Change United States Market
PRESS RELEASE

published on 04/18/2026 at 01:35, 13 days 23 hours ago

Medicure Announces Resignation of President and Chief Operating Officer
Medicure Inc. announces resignation of President and COO, Dr. Neil Owens. CEO Dr. Albert D. Friesen to assume responsibilities. Company remains focused on strategic priorities for the future

Pharmaceuticals Resignation Healthcare Medicure Inc. Leadership
BRIEF

published on 11/19/2025 at 23:05, 5 months 12 days ago

Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss

Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE

published on 11/19/2025 at 23:00, 5 months 12 days ago

Medicure Reports Financial Results for Quarter Ended September 30, 2025
Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights

Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF

published on 11/13/2025 at 23:35, 5 months 18 days ago

Medicure to Announce Q3 2025 Financial Results on November 20

Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE

published on 11/13/2025 at 23:30, 5 months 18 days ago

Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market

Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF

published on 08/20/2025 at 23:35, 8 months 12 days ago

Medicure Reports Q2 2025 Financial Results

Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE

published on 08/20/2025 at 23:30, 8 months 12 days ago

Medicure Reports Financial Results for Quarter Ended June 30, 2025
Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com

Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025

1 2 ... 6

Published on 05/02/2026 at 00:50, 19 minutes ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 hour 9 minutes ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 hour 9 minutes ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 2 hours 39 minutes ago

Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 22:30, 2 hours 39 minutes ago

Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing

View all ACCESSWIRE

Published on 05/01/2026 at 19:23, 5 hours 46 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 6 hours 29 minutes ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 7 hours 22 minutes ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 7 hours 24 minutes ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 7 hours 47 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS

Published on 04/30/2026 at 20:00, 1 day 5 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 5 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 6 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 6 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 1 day 7 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News